1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF GLOBAL GENOMICS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL GENOMICS MARKET SNAPSHOT
3.2 GLOBAL GENOMICS MARKET REVENUE, 2017 – 2025 (US$ BN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES
5.1 OVERVIEW
5.2 GLOBAL GENOMICS MARKET FOR INSTRUMENTS/SYSTEMS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
5.3 GLOBAL GENOMICS MARKET FOR, CONSUMABLES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
5.4 GLOBAL GENOMICS MARKET FOR SERVICES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6 GLOBAL GENOMICS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 GLOBAL GENOMICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.3 GLOBAL GENOMICS MARKET FOR DNA MICROARRAY, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.4 GLOBAL GENOMICS MARKET FOR DNA SEQUENCING, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.5 GLOBAL GENOMICS MARKET FOR, NUCLEIC ACID EXTRACTION AND PURIFICATION, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
6.6 GLOBAL GENOMICS MARKET FOR OTHERS (GENOTYPING AND GENE EDITING), VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7 GLOBAL GENOMICS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL GENOMICS MARKET FOR, DIAGNOSTICS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.3 GLOBAL GENOMICS MARKET FOR PERSONALIZED MEDICINE, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.4 GLOBAL GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.5 GLOBAL GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
7.6 GLOBAL GENOMICS MARKET FOR OTHERS (COALMINES,BIOFUELS AND MARINE RESEARCH) VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8 GLOBAL GENOMICS MARKET, BY PROCESS
8.1 OVERVIEW
8.2 GLOBAL GENOMICS MARKET FOR LIBRARY PREPARATION, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8.3 GLOBAL GENOMICS MARKET FOR GENE SEQUENCING, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
8.4 GLOBAL GENOMICS MARKET FOR DATA ANALYSIS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9 GLOBAL GENOMICS MARKET, BY END-USER
9.1 OVERVIEW
9.2 GLOBAL GENOMICS MARKET FOR, HOSPITALS AND CLINICS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.3 GLOBAL GENOMICS MARKET FOR RESEARCH CENTERS, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.4 GLOBAL GENOMICS MARKET FOR GOVERNMENT AND ACADEMIC INSTITUTES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.5 GLOBAL GENOMICS MARKET FOR PHARMACEUTICALS AND BIOTECHNOLOGICAL COMPANIES, VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
9.6 GLOBAL GENOMICS MARKET FOR OTHERS (SUCH AS NGO’S AND AGRI-GENOMICS ORGANIZATIONS) VOLUME AND REVENUE, 2017–2025, (UNITS) (US$ BN)
10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 MARKET DYNAMICS
10.1.1.1 Drivers
10.1.1.2 Restraints
10.1.1.3 Opportunity
10.1.2 U.S.
10.1.3 CANADA
10.1.4 MEXICO
10.2 EUROPE
10.2.1 MARKET DYNAMICS
10.2.1.1 Drivers
10.2.1.2 Restraints
10.2.1.3 Opportunity
10.2.2 U.K.
10.2.3 ITALY
10.2.4 FRANCE
10.2.5 GERMANY
10.2.6 RUSSIA
10.2.7 SPAIN
10.2.8 REST OF EUROPE
10.3 ASIA PACIFIC
10.3.1 MARKET DYNAMICS
10.3.1.1 Drivers
10.3.1.2 Restraints
10.3.1.3 Opportunity
10.3.2 INDIA
10.3.3 CHINA
10.3.4 JAPAN
10.3.5 AUSTRALIA
10.3.6 REST OF ASIA PACIFIC
10.4 MIDDLE EAST AND AFRICA
10.4.1 MARKET DYNAMICS
10.4.1.1 Drivers
10.4.1.2 Restraints
10.4.1.3 Opportunity
10.4.2 GCC
10.4.3 SOUTH AFRICA
10.4.4 REST OF MIDDLE EAST AND AFRICA
10.5 LATIN AMERICA
10.5.1 MARKET DYNAMICS
10.5.1.1 Drivers
10.5.1.2 Restraints
10.5.1.3 Opportunity
10.5.2 BRAZIL
10.5.3 REST OF LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 NEW PRODUCT LAUNCHES
12 GLOBAL GENOMICS MARKET, BY COMPANY
12.1 INTRODUCTION
12.2 AGILENT TECHNOLOGIES
12.2.1 BUSINESS OVERVIEW
12.2.2 PRODUCTS AND SERVICES
12.2.3 KEY STRATEGY
12.2.4 RECENT DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 OUR COMPANY VIEW
12.3 AFFYMETRIX, INC.
12.3.1 BUSINESS OVERVIEW
12.3.2 PRODUCTS AND SERVICES
12.3.3 KEY STRATEGY
12.3.4 RECENT DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 OUR COMPANY VIEW
12.4 BEIJING GENOMICS INSTITUTE (BGI)
12.4.1 BUSINESS OVERVIEW
12.4.2 PRODUCTS AND SERVICES
12.4.3 KEY STRATEGY
12.4.4 RECENT DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 OUR COMPANY VIEW
12.5 DANAHER
12.5.1 BUSINESS OVERVIEW
12.5.2 PRODUCTS AND SERVICES
12.5.3 KEY STRATEGY
12.5.4 RECENT DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 OUR COMPANY VIEW
12.6 EUROFINS SCIENTIFIC
12.6.1 BUSINESS OVERVIEW
12.6.2 PRODUCTS AND SERVICES
12.6.3 KEY STRATEGY
12.6.4 RECENT DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 OUR COMPANY VIEW
12.7 EPPENDORF
12.7.1 BUSINESS OVERVIEW
12.7.2 PRODUCTS AND SERVICES
12.7.3 KEY STRATEGY
12.7.4 RECENT DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 OUR COMPANY VIEW
12.8 F. HOFFMANN-LA ROCHE
12.8.1 BUSINESS OVERVIEW
12.8.2 PRODUCTS AND SERVICES
12.8.3 KEY STRATEGY
12.8.4 RECENT DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 OUR COMPANY VIEW
12.9 GE HEALTHCARE
12.9.1 BUSINESS OVERVIEW
12.9.2 PRODUCTS AND SERVICES
12.9.3 KEY STRATEGY
12.9.4 RECENT DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 OUR COMPANY VIEW
12.10 ILLUMINA INC.
12.10.1 BUSINESS OVERVIEW
12.10.2 PRODUCTS AND SERVICES
12.10.3 KEY STRATEGY
12.10.4 RECENT DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 OUR COMPANY VIEW
12.11 LIFE TECHNOLOGIES, INC.
12.11.1 BUSINESS OVERVIEW
12.11.2 PRODUCTS AND SERVICES
12.11.3 KEY STRATEGY
12.11.4 RECENT DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 OUR COMPANY VIEW
12.12 OXFORD NANOPORE TECHNOLOGIES
12.12.1 BUSINESS OVERVIEW
12.12.2 PRODUCTS AND SERVICES
12.12.3 KEY STRATEGY
12.12.4 RECENT DEVELOPMENTS
12.12.5 SWOT ANALYSIS
12.12.6 OUR COMPANY VIEW
12.13 PACIFIC BIOSCIENCES OF CALIFORNIA
12.13.1 BUSINESS OVERVIEW
12.13.2 PRODUCTS AND SERVICES
12.13.3 KEY STRATEGY
12.13.4 RECENT DEVELOPMENTS
12.13.5 SWOT ANALYSIS
12.13.6 OUR COMPANY VIEW
12.14 QIAGEN
12.14.1 BUSINESS OVERVIEW
12.14.2 PRODUCTS AND SERVICES
12.14.3 KEY STRATEGY
12.14.4 RECENT DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 OUR COMPANY VIEW
12.15 ROCHE DIAGNOSTICS
12.15.1 BUSINESS OVERVIEW
12.15.2 PRODUCTS AND SERVICES
12.15.3 KEY STRATEGY
12.15.4 RECENT DEVELOPMENTS
12.15.5 SWOT ANALYSIS
12.15.6 OUR COMPANY VIEW
12.16 THERMO FISHER SCIENTIFIC
12.16.1 BUSINESS OVERVIEW
12.16.2 PRODUCTS AND SERVICES
12.16.3 KEY STRATEGY
12.16.4 RECENT DEVELOPMENTS
12.16.5 SWOT ANALYSIS
12.16.6 OUR COMPANY VIEW